{
  "id": 8273691,
  "title": "U.S. regulators to examine testosterone therapy as use by menopausal women rises",
  "url": "https://urgent.news/2026/09/18/u-s-regulators-to-examine-testosterone-therapy-as-use-by-menopausal",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-18T17:17:54.000Z",
  "source": {
    "name": "The Hindu - Sci-Tech",
    "slug": "the-hindu-sci-tech",
    "url": "https://www.thehindu.com/sci-tech/health/us-regulators-to-examine-testosterone-therapy-as-use-by-menopausal-women-rises/article71482165.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "The U.S. Food and Drug Administration (FDA) is set to review the scientific evidence on testosterone use in menopausal women, as the number of women turning to the hormone to manage menopause symptoms rises. The FDA's public meeting aims to guide future research and drug development, addressing the lack of an FDA-approved testosterone therapy for women despite years of off-label use. Physicians often prescribe low doses of testosterone products approved for men or use compounded formulations, creating practical challenges for clinicians. The lack of a female-specific product raises concerns about standardised dosing, labeling, and safety-monitoring guidance. While some experts say more long-term safety data are needed, the United Kingdom, Australia, New Zealand, and South Africa have approved or licensed testosterone products specifically for women.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu Health",
        "title": "U.S. regulators to examine testosterone therapy as use by menopausal women rises",
        "url": "https://urgent.news/2026/09/18/u-s-regulators-to-examine-testosterone-therapy-as-use-by-menopausal-8279653",
        "published": "2026-09-18T17:17:54.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}